PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE: PHASE 3 TRIAL RESULTS

被引：0
|
作者：
Leebeek, Frank W. G. [1 ]
Peyvandi, Flora [2 ]
Escobar, Miguel [3 ]
Tiede, Andreas [4 ]
Castaman, Giancarlo [5 ]
Gu, Joan [6 ]
Mellgard, Bjorn [7 ]
Ewenstein, Bruce [7 ]
Ozen, Gulden [7 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Rotterdam, Netherlands
[2] Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[4] Hannover Med Sch, Hemostasis Oncol & Stem Cell Transplantat, Hannover, Germany
[5] Careggi Univ Hosp, Ctr Bleeding Disorders & Coagulat, Florence, Italy
[6] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[7] Takeda Dev Ctr Amer Inc, Cambridge, MA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E62 / E63
页数：2
相关论文
共 50 条
  • [1] Recombinant von Willebrand factor prophylaxis in patients with severe von Willebrand disease: phase 3 study results
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Escobar, Miguel
    Tiede, Andreas
    Castaman, Giancarlo
    Wang, Michael
    Wynn, Tung
    Baptista, Jovanna
    Wang, Yi
    Zhang, Jingmei
    Mellgard, Bjorn
    Ozen, Gulden
    [J]. BLOOD, 2022, 140 (02) : 89 - 98
  • [2] Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Tiede, Andreas
    Castaman, Giancarlo
    Escobar, Miguel
    Wang, Michael
    Zulfikar, Bulent
    Susen, Sophie
    Miesbach, Wolfgang
    Wang, Scarlett
    Wang, Yi
    Zhang, Jingmei
    Ozen, Gulden
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (01) : 29 - 40
  • [3] Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease
    Ragni, Margaret V.
    Castaman, Giancarlo
    Gill, Joan Cox
    Kouides, Peter
    Chapman, Miranda
    Sytkowski, Arthur
    Obermann-Slupetzky, Ortrun
    Presch, Isabella
    Fritsch, Sandor
    Ewenstein, Bruce M.
    [J]. BLOOD, 2015, 126 (23)
  • [4] PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE: POST HOC ANALYSIS FROM A PHASE 3 TRIAL
    Leebeek, Frank W. G.
    Escobar, Miguel
    Tiede, Andreas
    Wang, Michael
    Zulfikar, Bulent
    Wang, Scarlett
    Wang, Yi
    Ozen, Gulden
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E63 - E63
  • [5] Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery
    Peyvandi, F.
    Mamaev, A.
    Wang, J. -D.
    Stasyshyn, O.
    Timofeeva, M.
    Curry, N.
    Cid, A. R.
    Yee, T. T.
    Kavakli, K.
    Castaman, G.
    Sytkowski, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (01) : 52 - 62
  • [6] Safety, efficacy and pharmacokinetics of a recombinant von willebrand factor in patients with severe von willebrand disease: a prospective clinical trial
    Gill, J.
    Castaman, G.
    Windyga, J.
    Kouides, P.
    Ragni, M.
    Leebeek, F.
    Obermann-Slupetzky, O.
    Chapman, M.
    Fritsch, S.
    Pavlova, B. G.
    Presch, I
    Ewenstein, B.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 127 - 127
  • [7] Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Comment
    Miesbach, Wolfgang
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (08) : 1403 - 1405
  • [8] Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply
    Peyvandi, Flora
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (08) : 1405 - 1406
  • [9] Efficacy and Safety of a Recombinant von Willebrand Factor for Bleed Treatment in Patients with Severe von Willebrand Disease
    Gill, J.
    Castaman, G.
    Windyga, J.
    Kouides, P.
    Ragni, M.
    Leebeek, F.
    [J]. HAEMOPHILIA, 2015, 21 (03) : E263 - E263
  • [10] Recombinant von willebrand factor kinetics and ultralarge multimer content in severe von willebrand disease patients
    Ragni, M.
    Castaman, G.
    Gill, J. C.
    Kouides, P.
    Chapman, M.
    Sytkowski, A.
    Obermann-Slupetzky, O.
    Presch, I
    Fritsch, S.
    Ewenstein, B.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 151 - 151
12345